| 1BOZ | A: | STRUCTURE-BASED DESIGN AND SYNTHESIS OF LIPOPHILIC 2,4-DIAMINO-6-SUBSTITUTED QUINAZOLINES AND THEIR EVALUATION AS INHIBITORS OF DIHYDROFOLATE REDUCTASE AND POTENTIAL ANTITUMOR AGENTS |
| 1DHF | A:; B: | CRYSTAL STRUCTURES OF RECOMBINANT HUMAN DIHYDROFOLATE REDUCTASE COMPLEXED WITH FOLATE AND 5-DEAZOFOLATE |
| 1DLR | A: | METHOTREXATE-RESISTANT VARIANTS OF HUMAN DIHYDROFOLATE REDUCTASE WITH SUBSTITUTION OF LEUCINE 22: KINETICS, CRYSTALLOGRAPHY AND POTENTIAL AS SELECTABLE MARKERS |
| 1DLS | A: | METHOTREXATE-RESISTANT VARIANTS OF HUMAN DIHYDROFOLATE REDUCTASE WITH SUBSTITUTION OF LEUCINE 22: KINETICS, CRYSTALLOGRAPHY AND POTENTIAL AS SELECTABLE MARKERS |
| 1DRF | A: | CRYSTAL STRUCTURE OF HUMAN DIHYDROFOLATE REDUCTASE COMPLEXED WITH FOLATE |
| 1HFP | A: | COMPARISON OF TERNARY CRYSTAL COMPLEXES OF HUMAN DIHYDROFOLATE REDUCTASE WITH NADPH AND A CLASSICAL ANTITUMOR FUROPYRIMDINE |
| 1HFQ | A: | COMPARISON OF TERNARY CRYSTAL COMPLEXES OF HUMAN DIHYDROFOLATE REDUCTASE WITH NADPH AND A CLASSICAL ANTITUMOR FUROPYRIMDINE |
| 1HFR | A: | COMPARISON OF TERNARY CRYSTAL COMPLEXES OF HUMAN DIHYDROFOLATE REDUCTASE WITH NADPH AND A CLASSICAL ANTITUMOR FUROPYRIMDINE |
| 1KMS | A: | HUMAN DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND 6-([5-QUINOLYLAMINO]METHYL)-2,4-DIAMINO-5-METHYLPYRIDO[2,3-D]PYRIMIDINE (SRI-9439), A LIPOPHILIC ANTIFOLATE |
| 1KMV | A: | HUMAN DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND (Z)-6-(2-[2,5-DIMETHOXYPHENYL]ETHEN-1-YL)-2,4-DIAMINO-5-METHYLPYRIDO[2,3-D]PYRIMIDINE (SRI-9662), A LIPOPHILIC ANTIFOLATE |
| 1MVS | A: | ANALYSIS OF TWO POLYMORPHIC FORMS OF A PYRIDO[2,3-D]PYRIMIDINE N9-C10 REVERSE-BRIDGE ANTIFOLATE BINARY COMPLEX WITH HUMAN DIHYDROFOLATE REDUCTASE |
| 1MVT | A: | ANALYSIS OF TWO POLYMORPHIC FORMS OF A PYRIDO[2,3-D]PYRIMIDINE N9-C10 REVERSE-BRIDGE ANTIFOLATE BINARY COMPLEX WITH HUMAN DIHYDROFOLATE REDUCTASE |
| 1OHJ | A: | HUMAN DIHYDROFOLATE REDUCTASE, MONOCLINIC (P21) CRYSTAL FORM |
| 1OHK | A: | HUMAN DIHYDROFOLATE REDUCTASE, ORTHORHOMBIC (P21 21 21) CRYSTAL FORM |
| 1PD8 | A: | ANALYSIS OF THREE CRYSTAL STRUCTURE DETERMINATIONS OF A 5-METHYL-6-N-METHYLANILINO PYRIDOPYRIMIDINE ANTIFOLATE COMPLEX WITH HUMAN DIHYDROFOLATE REDUCTASE |
| 1PD9 | A: | ANALYSIS OF THREE CRYSTAL STRUCTURE DETERMINATIONS OF A 5-METHYL-6-N-METHYLANILINO PYRIDOPYRIMIDINE ANTIFOLATE COMPLEX WITH HUMAN DIHYDROFOLATE REDUCTASE |
| 1PDB | A: | ANALYSIS OF THREE CRYSTAL STRUCTURE DETERMINATIONS OF A 5-METHYL-6-N-METHYLANILINO PYRIDOPYRIMIDINE ANTIFOLATE COMPLEX WITH HUMAN DIHYDROFOLATE REDUCTASE |
| 1S3U | A: | STRUCTURE DETERMINATION OF TETRAHYDROQUINAZOLINE ANTIFOLATES IN COMPLEX WITH HUMAN AND PNEUMOCYSTIS CARINII DIHYDROFOLATE REDUCTASE: CORRELATIONS OF ENZYME SELECTIVITY AND STEREOCHEMISTRY |
| 1S3V | A: | STRUCTURE DETERMINATION OF TETRAHYDROQUINAZOLINE ANTIFOLATES IN COMPLEX WITH HUMAN AND PNEUMOCYSTIS CARINII DIHYDROFOLATE REDUCTASE: CORRELATIONS OF ENZYME SELECTIVITY AND STEREOCHEMISTRY |
| 1S3W | A: | STRUCTURE DETERMINATION OF TETRAHYDROQUINAZOLINE ANTIFOALTES IN COMPLEX WITH HUMAN AND PNEUMOCYSTIS CARINII DIHYDROFOLATE REDUCTASE: CORRELATIONS OF ENZYME SELECTIVITY AND STEREOCHEMISTRY |
| 1U71 | A: | UNDERSTANDING THE ROLE OF LEU22 VARIANTS IN METHOTREXATE RESISTANCE: COMPARISON OF WILD-TYPE AND LEU22ARG VARIANT MOUSE AND HUMAN DIHYDROFOLATE REDUCTASE TERNARY CRYSTAL COMPLEXES WITH METHOTREXATE AND NADPH |
| 1U72 | A: | UNDERSTANDING THE ROLE OF LEU22 VARIANTS IN METHOTREXATE RESISTANCE: COMPARISON OF WILD-TYPE AND LEU22ARG VARIANT MOUSE AND HUMAN DIHYDRFOLATE REDUCTASE TERNARY CRYSTAL COMPLEXES WITH METHOTREXATE AND NADPH |
| 1YHO | A: | SOLUTION STRUCTURE OF HUMAN DIHYDROFOLATE REDUCTASE COMPLEXED WITH TRIMETHOPRIM AND NADPH, 25 STRUCTURES |
| 2C2S | A:; B: | HUMAN DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND 2,4-DIAMINO-5-(1-O-CARBORANYLMETHYL)-6-METHYLPYRIMIDINE, A NOVEL BORON CONTAINING, NONCLASSICAL ANTIFOLATE |
| 2C2T | A:; B: | HUMAN DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND 2,4-DIAMINO-5-((7,8-DICARBAUNDECABORAN-7-YL)METHYL)-6-METHYLPYRIMIDINE, A NOVEL BORON CONTAINING, NONCLASSICAL ANTIFOLATE |
| 2DHF | A:; B: | CRYSTAL STRUCTURES OF RECOMBINANT HUMAN DIHYDROFOLATE REDUCTASE COMPLEXED WITH FOLATE AND 5-DEAZOFOLATE |
| 2W3A | A:; B: | HUMAN DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND TRIMETHOPRIM |
| 2W3B | A:; B: | HUMAN DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND A LIPOPHILIC ANTIFOLATE SELECTIVE FOR MYCOBACTERIUM AVIUM DHFR, 6-((2,5-DIETHOXYPHENYL)AMINOMETHYL)-2,4-DIAMINO-5-METHYLPYRIDO(2,3-D)PYRIMIDINE (SRI-8686) |
| 2W3M | A:; B: | HUMAN DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND FOLATE |
| 3EIG | A: | CRYSTAL STRUCTURE OF A METHOTREXATE-RESISTANT MUTANT OF HUMAN DIHYDROFOLATE REDUCTASE |
| 3F8Y | A: | CORRELATIONS OF HUMAN DIHYDROFOLATE REDUCTASE WITH STRUCTURAL DATA FOR HUMAN ACTIVE SITE MUTANT ENZYME COMPLEXES |
| 3F8Z | A: | HUMAN DIHYDROFOLATE REDUCTASE STRUCTURAL DATA WITH ACTIVE SITE MUTANT ENZYME COMPLEXES |
| 3F91 | A: | STRUCTURAL DATA FOR HUMAN ACTIVE SITE MUTANT ENZYME COMPLEXES |
| 3FS6 | A: | CORRELATIONS OF INHIBITOR KINETICS FOR PNEUMOCYSTIS JIROVECII AND HUMAN DIHYDROFOLATE REDUCTASE WITH STRUCTURAL DATA FOR HUMAN ACTIVE SITE MUTANT ENZYME COMPLEXES |
| 3GHC | A: | DESIGN, SYNTHESIS, AND X-RAY CRYSTAL STRUCTURE OF CLASSICAL AND NONCLASSICAL 2-AMINO-4-OXO-5-SUBSTITUTED-6-THIENO[2,3-D]PYRIMIDINES AS DUAL THYMIDYLATE SYNTHASE AND DIHYDROFOLATE REDUCTASE INHIBITORS AND AS POTENTIAL ANTITUMOR AGENST |
| 3GHV | A: | HUMAN DIHYDROFOLATE REDUCTASE Q35K/N64F DOUBLE MUTANT INHIBITOR COMPLEX |
| 3GHW | A: | HUMAN DIHYDROFOLATE REDUCTASE INHIBITOR COMPLEX |
| 3GI2 | A: | HUMAN DIHYDROFOLATE REDUCTASE Q35K MUTANT INHIBITOR COMPLEX |
| 3GYF | A: | HUMAN DHFR WITH Z-ISOMER IN ORTHORHOMBIC LATTICE |
| 3L3R | A: | STRUCTURAL, COMPUTATIONAL AND KINETIC DATA FOR ANTIFOLATE INTERACTIONS AGAINST PNEUMOCYSTIS JIROVECII, PNEUMOCYSTIS CARINII AND HUMAN DIHYDROFOLATE REDUCTASE AND THEIR ACTIVE SITE MUTANTS |
| 3NTZ | A: | DESIGN, SYNTHESIS, BIOLOGICAL EVALUATION AND X-RAY CRYSTAL STRUCTURES OF NOVEL CLASSICAL 6,5,6-TRICYCLICBENZO[4,5]THIENO[2,3-D]PYRIMIDINES AS DUAL THYMIDYLATE SYNTHASE AND DIHYDROFOLATE REDUCTASE INHIBITORS |
| 3NU0 | A: | DESIGN, SYNTHESIS, BIOLOGICAL EVALUATION AND X-RAY CRYSTAL STRUCTURE OF NOVEL CLASSICAL 6,5,6-TRICYCLICBENZO[4,5]THIENO[2,3-D]PYRIMIDINES AS DUAL THYMIDYLATE SYNTHASE AND DIHYDROFOLATE REDUCTASE INHIBITORS |
| 3NXO | A: | PERFERENTIAL SELECTION OF ISOMER BINDING FROM CHIRAL MIXTURES: ALTERNATE BINDING MODES OBSERVED FOR THE E- AND Z-ISOMERS OF A SERIES OF 5-SUBSTITUTED 2,4-DIAMINOFURO[2,3-D]PYRIMIDINES AS TERNARY COMPLEXES WITH NADPH AND HUMAN DIHYDROFOLATE REDUCTASE |
| 3NXR | A: | PERFERENTIAL SELECTION OF ISOMER BINDING FROM CHIRAL MIXTURES: ALTERNATE BINDING MODES OBSERVED FOR THE E- AND Z-ISOMERS OF A SERIES OF 5-SUBSTITUTED 2,4-DIAMINOFURO[2,3-D]PYRIMIDINES AS TERNARY COMPLEXES WITH NADPH AND HUMAN DIHYDROFOLATE REDUCTASE |
| 3NXT | A: | PREFERENTIAL SELECTION OF ISOMER BINDING FROM CHIRAL MIXTURES: ALTERNATE BINDING MODES OBSERVED FOR THE E-AND Z-ISOMERS OF A SERIES OF 5-SUBSTITUTED 2,4-DIAMINOFURO[2M,3-D]PYRIMIDINES AS TERNARY COMPLEXES WITH NADPH AND HUMAN DIHYDROFOLATE REDUCTASE |
| 3NXV | A: | PREFERENTIAL SELECTION OF ISOMER BINDING FROM CHIRAL MIXTURES: ALTERNATE BINDING MODES OBSERVED FOR THE E- AND Z-ISOMERS OF A SERIES OF 5-SUBSTITUTED 2,4-DIAMINOFURO[2,3-D]PYRIMIDINES AS TERNARY COMPLEXES WITH NADPH AND HUMAN DIHYDROFOLATE REDUCTASE |
| 3NXX | A: | PREFERENTIAL SELECTION OF ISOMER BINDING FROM CHIRAL MIXTURES: ALTERNATE BINDING MODES OBSERVED FOR THE E- AND Z-ISOMERS OF A SERIES OF 5-SUBSTITUTED 2,4-DIAMINOFURO-2,3-D]PYRIMIDINES AS TERNARY COMPLEXES WITH NADPH AND HUMAN DIHYDROFOLATE REDUCTASE |
| 3NXY | A: | PREFERENTIAL SELECTION OF ISOMER BINDING FROM CHIRAL MIXTURES: ALERNATE BINDING MODES OBSERVED FRO THE E- AND Z-ISOMERS OF A SERIES OF 5-SUBSTITUTED 2,4-DIAMINOFURO[2,3-D]PYRIMIDINES AS TERNARY COMPLEXES WITH NADPH AND HUMAN DIHYDROFOLATE REDUCTASE |
| 3NZD | A: | STRUCTURAL ANALYSIS OF PNEUMOCYSTIS CARINII AND HUMAN DHFR COMPLEXES WITH NADPH AND A SERIES OF FIVE 5-(OMEGA-CARBOXY(ALKYLOXY(PYRIDO[2,3-D]PYRIMIDINE DERIVATIVES |
| 3OAF | A: | STRUCTURAL AND KINETIC DATA FOR ANTIFOLATE INTERACTIONS AGAINST PNEUMOCYSTIS JIROVECII, PNEUMOCYSTIS CARINII AND HUMAN DIHYDROFOLATE REDUCTASE AND THIER ACTIVE SITE MUTANTS |
| 3S7A | A: | HUMAN DIHYDROFOLATE REDUCTASE BINARY COMPLEX WITH PT684 |
| 4DDR | A: | HUMAN DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND P218 |
| 4G95 | A: | HDHFR-OAG BINARY COMPLEX |
| 4KAK | A:; B: | CRYSTAL STRUCTURE OF HUMAN DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND 6-ETHYL-5-[(3S)-3-[3-METHOXY-5-(PYRIDINE-4-YL)PHENYL]BUT-1-YN-1-YL]PYRIMIDINE-2,4-DIAMINE (UCP1006) |
| 4KBN | A:; B: | HUMAN DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND 5-{3-[3-(3,5-PYRIMIDINE)]-PHENYL-PROP-1-YN-1-YL}-6-ETHYL-PYRIMIDINE-2,4DIAMINE |
| 4KD7 | A:; B: | HUMAN DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND 5-{3-[3-METHOXY-5(PYRIDINE-4-YL)PHENYL]PROP-1-YN-1-YL}-6-ETHYL-PYRIMIDINE-2, 4-DIAMINE |
| 4KEB | A:; B: | HUMAN DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND 5-{3-[3-METHOXY-5-(ISOQUIN-5-YL)PHENYL]BUT-1-YN-1-YL}6-ETHYLPYRIMIDINE-2,4-DIAMINE |
| 4KFJ | A:; B: | HUMAN DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND 5-{3-[3-METHOXY-5-(ISOQUIN-5-YL)PHENYL]PROP-1-YN-1-YL}6-ETHYLPRIMIDINE-2,4-DIAMINE |
| 4M6J | A: | CRYSTAL STRUCTURE OF HUMAN DIHYDROFOLATE REDUCTASE (DHFR) BOUND TO NADPH |
| 4M6K | A: | CRYSTAL STRUCTURE OF HUMAN DIHYDROFOLATE REDUCTASE (DHFR) BOUND TO NADP+ AND FOLATE |
| 4M6L | A: | CRYSTAL STRUCTURE OF HUMAN DIHYDROFOLATE REDUCTASE (DHFR) BOUND TO NADP+ AND 5,10-DIDEAZATETRAHYDROFOLIC ACID |
)
)